$58.54 -0.42 (%) Merck & Co Inc - NYSE

Feb. 27, 2015 | 04:00 PM

Partner Headlines

  1. Heavy News Day For Several Biotech Stocks

    Benzinga | Feb. 25, 2015 | 15:34PM EST
  2. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  3. PRIMECAP Management's New Positions

    GuruFocus | Feb. 13, 2015 | 15:47PM EST
  4. Microsoft Does Largest Corporate Debt Sale Of Year

    IBD | Feb. 9, 2015 | 16:59PM EST
  5. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD | Feb. 9, 2015 | 16:53PM EST
  6. Gabelli's Q4 Picks Include Acquisition Targets

    GuruFocus | Feb. 6, 2015 | 10:44AM EST
  7. Fast Money Halftime Report Final Trade From February 5

    Benzinga | Feb. 6, 2015 | 06:45AM EST
  8. Gilead Sciences Falls 10% After More Than Doubling Drug Discounts For 2015

    GuruFocus | Feb. 5, 2015 | 11:35AM EST
  9. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  10. Merck hep C drug faces delays

    IBD | Feb. 4, 2015 | 19:29PM EST
  11. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  12. UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline

    Benzinga | Feb. 4, 2015 | 08:03AM EST
  13. Earnings Scheduled For February 4, 2015

    Benzinga | Feb. 4, 2015 | 05:08AM EST
  14. Keep an Eye on These 10 Stocks for February 4, 2015

    Benzinga | Feb. 4, 2015 | 04:08AM EST
  15. Irving Kahn Adds to Stakes in Three Companies in Q4

    GuruFocus | Feb. 3, 2015 | 16:18PM EST
  16. What Investors Are Watching For In Regulus Therapeutics' Next Data Release

    Benzinga | Jan. 30, 2015 | 14:32PM EST
  17. Fast Money Halftime Report Final Trade From January 27

    Benzinga | Jan. 27, 2015 | 21:27PM EST
  18. White House Budget To Support Biotech Rally

    Benzinga | Jan. 27, 2015 | 16:00PM EST
  19. Putting Recent Layoff Reports in Economic Perspective

    FoxBusiness | Jan. 26, 2015 | 13:02PM EST
  20. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  21. The 5 Best Dow Stocks So Far In 2015

    Benzinga | Jan. 20, 2015 | 17:33PM EST
  22. World Economic Forum 2015 - What To Look Forward For

    GuruFocus | Jan. 18, 2015 | 07:40AM EST
  23. Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks

    Benzinga | Jan. 16, 2015 | 15:12PM EST
  24. Merck Takes A Step Forward In The World Of Medicine

    GuruFocus | Jan. 16, 2015 | 11:23AM EST
  25. Fast Money Halftime Report Final Trade From January 14

    Benzinga | Jan. 15, 2015 | 06:26AM EST
  26. Top Cybersecurity Stock Qualys Gets Support

    IBD | Jan. 13, 2015 | 17:42PM EST
  27. Stocks Rumble Ahead Despite Oil; Alaska Air, Celgene, Apple Jump

    IBD | Jan. 13, 2015 | 10:34AM EST
  28. Bristol-Myers Hits 14-Year High On Cancer Drug Trial

    IBD | Jan. 12, 2015 | 14:25PM EST
  29. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  30. Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014

    GuruFocus | Jan. 9, 2015 | 10:25AM EST
  31. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  32. Stock Indexes Gun For Best Pop In 3 Weeks; Monster Breaks Out

    IBD | Jan. 7, 2015 | 14:48PM EST
  33. Stocks Drop 1% In Rising Volume; Visa Falls 1%

    IBD | Jan. 5, 2015 | 10:33AM EST
  34. Ebola Drug Work Continues

    IBD | Dec. 26, 2014 | 18:22PM EST
  35. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  36. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  37. FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities

    Benzinga | Dec. 23, 2014 | 15:22PM EST
  38. Indexes Turn Mixed On Data; Celgene Dives

    IBD | Dec. 23, 2014 | 10:43AM EST
  39. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD | Dec. 22, 2014 | 10:34AM EST
  40. NewLink Genetics Surges 3% Following Ebola Contract News

    Benzinga | Dec. 22, 2014 | 09:32AM EST
  41. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  42. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
  43. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD | Dec. 11, 2014 | 14:25PM EST
  44. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  45. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  46. Merck repurposes cancer drug

    IBD | Dec. 10, 2014 | 18:43PM EST
  47. Merck's Keytruda Might Treat Virulent Breast Cancer

    IBD | Dec. 10, 2014 | 11:04AM EST
  48. Data Investigating KEYTRUDA, Merck's Anti-PD-1 Therapy, In Patients With Advanced Triple-Negative Breast Cancer Presented At 2014 San Antonio Breast Cancer Symposium

    Benzinga | Dec. 10, 2014 | 08:34AM EST
  49. Merck-Cubist deal going ahead

    IBD | Dec. 9, 2014 | 18:42PM EST
  50. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
Trading Center